It was approved by the US Food and Drug Administration (FDA) on 1 April 2026 and is the second oral GLP-1 weight loss treatment to receive FDA approval, following the Wegovy tablet (oral semaglutide) in December 2025
If your symptoms get worse or there is no improvement, be sure to call a doctor
10.1186/1710-1492-10-43 215 JiaL.XiaoL.FuY.ShaoZ.JingZ.YuanJ.et al
In Europe, the European Medicines Agency (EMA) has initiated reviews to further examine whether drugs like semaglutide may increase risk for depression or other mood-related side effects
Buy Tirzepatide (Mounjaro) in Thailand (Bangkok, Phuket, Pattaya, Chiang Mai & Koh Samui) Safe Weight Loss & Diabetes Care 2852 Safe & effective Tirzepatide (Mounjaro) for weight loss and diabetes care in Thailand, available in Bangkok, Phuket, Pattaya, Chiang Mai and Ko Samui